Adjuvants enhancing an integral immune response to antigens. 15-17 September, 2004, Modern Vaccine/Adjuvant Formulation: impact on future development (MVAF 2004), Prague.
van der Laan
Jan Willem
JW
National Institute for Public Health and the Environment, Centre for Biological Medicines and Medical Technology, The Netherlands. jan-willem.van.der.laan@rivm.nl
D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000627:therapeutic use; D000818:Animals; D000941:Antigens / Q000276:immunology*; D001424:Bacterial Infections / Q000188:drug therapy / Q000276:immunology; D001428:Bacterial Vaccines / Q000008:administration & dosage* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D016503:Drug Delivery Systems; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D006801:Humans; D008081:Liposomes; D051193:Toll-Like Receptors / Q000276:immunology; D019444:Vaccines, DNA / Q000008:administration & dosage / Q000627:therapeutic use; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000627:therapeutic use; D022701:Virosomes
D000276:Adjuvants, Immunologic; D000941:Antigens; D001428:Bacterial Vaccines; D008081:Liposomes; D051193:Toll-Like Receptors; D019444:Vaccines, DNA; D014614:Vaccines, Synthetic; D022701:Virosomes